Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP193375.RAS-2QUB56kFdL9N1-TTEOaFeMAk8_aOfCu9TZfVngkiw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP193375.RAS-2QUB56kFdL9N1-TTEOaFeMAk8_aOfCu9TZfVngkiw130_assertion type Assertion NP193375.RAS-2QUB56kFdL9N1-TTEOaFeMAk8_aOfCu9TZfVngkiw130_head.
- NP193375.RAS-2QUB56kFdL9N1-TTEOaFeMAk8_aOfCu9TZfVngkiw130_assertion description "[Our identification of XRCC2 as a breast cancer susceptibility gene thus increases the proportion of breast cancers that are associated with homologous recombination-DNA-repair dysfunction and Fanconi anemia and could therefore benefit from specific targeted treatments such as PARP (poly ADP ribose polymerase) inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP193375.RAS-2QUB56kFdL9N1-TTEOaFeMAk8_aOfCu9TZfVngkiw130_provenance.
- NP193375.RAS-2QUB56kFdL9N1-TTEOaFeMAk8_aOfCu9TZfVngkiw130_assertion evidence source_evidence_literature NP193375.RAS-2QUB56kFdL9N1-TTEOaFeMAk8_aOfCu9TZfVngkiw130_provenance.
- NP193375.RAS-2QUB56kFdL9N1-TTEOaFeMAk8_aOfCu9TZfVngkiw130_assertion SIO_000772 22464251 NP193375.RAS-2QUB56kFdL9N1-TTEOaFeMAk8_aOfCu9TZfVngkiw130_provenance.
- NP193375.RAS-2QUB56kFdL9N1-TTEOaFeMAk8_aOfCu9TZfVngkiw130_assertion wasDerivedFrom befree-20140225 NP193375.RAS-2QUB56kFdL9N1-TTEOaFeMAk8_aOfCu9TZfVngkiw130_provenance.
- NP193375.RAS-2QUB56kFdL9N1-TTEOaFeMAk8_aOfCu9TZfVngkiw130_assertion wasGeneratedBy ECO_0000203 NP193375.RAS-2QUB56kFdL9N1-TTEOaFeMAk8_aOfCu9TZfVngkiw130_provenance.